Pulmonx Corporation
LUNG
$1.25
-$0.13-9.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.50% | 20.87% | 1.32% | 1.00% | -5.08% |
| Total Depreciation and Amortization | -56.83% | -15.99% | -47.10% | -40.20% | -13.93% |
| Total Amortization of Deferred Charges | 1,227.27% | 4.49% | 2.70% | 115.12% | -90.52% |
| Total Other Non-Cash Items | -14.88% | -10.75% | -0.47% | -19.72% | -6.90% |
| Change in Net Operating Assets | 67.01% | -313.05% | -115.52% | 255.72% | -3.33% |
| Cash from Operations | 23.63% | -5.26% | -12.70% | 32.27% | -12.10% |
| Capital Expenditure | 97.01% | 88.29% | 78.61% | 89.55% | 33.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 22.78% | 1,608.20% | 908.07% |
| Cash from Investing | -100.06% | -100.09% | 29.03% | 755.21% | 750.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -4.08% | -- | -4.35% | -- |
| Issuance of Common Stock | -63.70% | -4.50% | -55.34% | 16.67% | -23.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 205.12% | -11.29% | -60.57% | -204.55% | -23.15% |
| Foreign Exchange rate Adjustments | 4.76% | 24.87% | 398.32% | -1,167.39% | -318.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -324.11% | -189.58% | 818.54% | 113.68% | 127.26% |